The values that guide our decision-making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.
Robert Wood Johnson, former chairman from 1932 to 1963 and a member of the Company’s founding family, drafted Our Credo himself in 1943, just before Johnson & Johnson became a publicly traded company. This was long before anyone ever heard the term “corporate social responsibility.” Our Credo is more than just a moral compass. We believe it’s a recipe for business success. The fact that Johnson & Johnson is one of only a handful of companies that have flourished through more than a century of change is evidence of that.
Johnson & Johnson Vision envisions a future where preventable vision loss and blindness are relics of the past. A future where access is improved in communities of need. A future where eye care professionals, institutions and industry work together to change the experience for patients. A future where smart-device technologies, computer-assisted surgeries and customization for a patient’s eye health needs become the norm. To help create this reality, we are making significant investments in new science and technologies as well as insights and analytics. Our research agenda addresses a broad spectrum of eye disease - from myopia that often strikes children at a young age through to advanced macular disease. And we have in late-stage development brand new categories of contact lenses that have the potential to deliver benefits beyond vision correction.
Our mission is bringing science and sense of sight to life through world-class innovation and customer experience.
We aspire to help people:
Johnson & Johnson Vision envisions a future where preventable vision loss and blindness are relics of the past. A future where access is improved in communities of need. A future where eye care professionals, institutions and industry work together to change the experience for patients. A future where smart-device technologies, computer-assisted surgeries and customization for a patient’s eye health needs become the norm. To help create this reality, we are making significant investments in new science and technologies as well as insights and analytics.
Our research agenda addresses a broad spectrum of eye disease - from myopia that often strikes children at a young age through to advanced macular disease. And we have in late-stage development brand new categories of contact lenses that have the potential to deliver benefits beyond vision correction.
Together, we will deliver 15 new category shaping products over the next 5 years.
We are committed to bringing 2 new Contact Lens products to market annually through 2020.
Watch our contact lens innovators reveal our EYE-INSPIRED™ Innovation story.
Did you know that 19 million children are visually impaired? Sight for Kids has provided school-based eye health education and vision screening to more than 25 million kids around the world with Lions Clubs International Foundation and local partners. Through Sight for Kids, we have provided access to eye health education and services, including free exams and eyeglasses, to approximately 500,000 children. Together, with our local partners, we aspire to double the number of children helped through Sight for Kids by 2021.
